Company Threshold Pharmaceuticals, Inc. Nasdaq
Equities
US8858072064
Biotechnology & Medical Research
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Biologic Therapeutics for Cancer
100.0
%
| 20 | 100.0 % | 53 | 100.0 % | +166.40% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 17 | 86.9 % | 53 | 100.0 % | +206.53% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Eric Poma
CEO | Chief Executive Officer | 52 | 01/00/01 |
Jason Kim
PSD | President | 49 | 01/10/01 |
Kristen Quigley
COO | Chief Operating Officer | 53 | 01/17/01 |
Gabriela Gruia
BRD | Director/Board Member | 67 | 01/22/01 |
Grace Kim
IRC | Investor Relations Contact | - | 02/23/02 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Eric Poma
CEO | Chief Executive Officer | 52 | 01/00/01 |
Harold Selick
CHM | Chairman | 69 | 01/17/01 |
David Hoffmann
BRD | Director/Board Member | 79 | 01/17/01 |
Kevin Lalande
BRD | Director/Board Member | 51 | 01/09/01 |
Corazon Sanders
BRD | Director/Board Member | 67 | 19/19/19 |
Gabriela Gruia
BRD | Director/Board Member | 67 | 01/22/01 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 6,583,880 | 6,323,103 ( 96.04 %) | 0 | 96.04 % |
Company contact information
Molecular Templates, Inc.
9301 Amberglen Boulevard Suite 100
78729, Austin
+512 869 1555
http://www.mtem.com![address Threshold Pharmaceuticals, Inc.](https://cdn.zonebourse.com/static/address/4706838.png)
Sector
Sales per region
1st Jan change | Capi. | |
---|---|---|
+20.03% | 126B | |
+23.61% | 118B | |
+23.26% | 27.87B | |
-18.07% | 20.95B | |
-15.13% | 16.92B | |
-14.81% | 16.18B | |
+9.78% | 14.84B | |
-46.10% | 14.79B | |
+52.34% | 14.08B |